PlainRecalls
FDA Drug Low Class III Terminated

Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack)

Reported: December 26, 2018 Initiated: December 7, 2018 #D-1207-2019

Product Description

Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack)

Reason for Recall

Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.

Details

Units Affected
47,520 prescription packs
Distribution
Nationwide in the USA
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack). Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: 47,520 prescription packs.
Why was this product recalled?
Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 26, 2018. Severity: Low. Recall number: D-1207-2019.